R&D
4th Circular & Self-Amplifying RNA Therapeutics Summit
Partner Content

4th Circular & Self-Amplifying RNA Therapeutics Summit

With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-am

R&D
4th Circular & Self-Amplifying RNA Therapeutics Summit
Partner Content

4th Circular & Self-Amplifying RNA Therapeutics Summit

With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-am